US FDA Would Get Mandatory Recall Authority For Drugs Under House Funding Bill
Executive Summary
The change would let FDA forcibly pull prescription and over-the-counter drugs off the market just like vaccines, medical devices and other products.
You may also be interested in...
House Would Slow US FDA Budget Authority Increases In FY 2021
After two years of significant growth in non-user fee funds, House appropriators offer FDA a more modest increase for FY 2021.
Senators Press For More Surprise Drug GMP Inspections Abroad
US FDA officials grilled during first Senate Finance Committee hearing in months over practice of preannouncing foreign inspections.
COVID-19 Funds Flow To Startup In Bid To Restore US Pharmaceutical Manufacturing
Trump administration infuses Phlow with potentially $800m-plus for fully integrated domestic manufacture of essential medicines for COVID-19 and other crises. Key figures in new approaches to securing drugs and experts on China helped frame the project’s approach.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: